Seres Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $342.9M
Liabilities Breakdown FY2020
Total Liabilities: $168.2M
Asset Breakdown
Total Assets: $342.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $116.0M | 33.8% |
| Accounts Receivable | $9.4M | 2.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.9M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $203.6M | 59.4% |
Liabilities Breakdown
Total Liabilities: $168.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.0M | 2.4% |
| Long-Term Debt | $25.0M | 14.9% |
| Other Liabilities | $139.2M | 82.7% |